Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q2 2023 Earnings Call Transcript August 4, 2023 8:30 AM ET Company Participants Mike Beaulieu - Vice President of Investor Relations Rob Spignesi - CEO, President and Director Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Operator Ladies and gentlemen, thank you for standing by, and welcome to Rapid Micro Biosystems' Q2 2023 Earnings Call. [Operator Instructions] I would now like to turn the confere ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File Numbe ...

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2023 Earnings Conference Call May 5, 2023 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Operator Good morning, and welcome to the Rapid Micro Biosystems First Quarter Financial Results Call. All lines have been placed on mute to prevent any background noise. [Operator Instructions] And finally, I ...

Table of Contents For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40592 Rapid Micro Biosystems, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-8121647 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1001 Pawtucket Boulevard West, Suite 280 Lowell, MA 01854 (Address of principal exec ...

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2022 Results Conference Call March 3, 2023 8:30 AM ET Company Participants Mike Beaulieu - VP, IR & Corporate Communications Rob Spignesi - President, CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias - Stifel Tejas Savant - Morgan Stanley Rachel Vatnsdal - JP Morgan Stephanie Yan - Cowen Operator Good morning, and welcome to Rapid Micro Biosystems Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this ...

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Rachel Vatnsdal - JPMorgan Stephanie Yan - Cowen Operator Hello. My name is Lisa and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems Third Quarter 2022 Ea ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File N ...

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations & Corporate Communications Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Stephanie Yan - Cowen Rachel Cascio - JPMorgan Operator Ladies and gentlemen, thank you for standing by and welcome to the Rapid Micro Biosystems Second Q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40592 Rapid Micro Biosystems, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8121647 ...

Rapid Micro Biosystems Inc. (NASDAQ:RPID) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Noah Burhance - JPMorgan Operator Good day, and thank you for standing by. Welcome to the Rapid Micro Biosystems First Quarter 2022 Earnings Conference Ca ...